Safety and immunogenicity of an mRNA-lipid nanoparticle vaccine candidate against SARS-CoV-2A phase 1 randomized clinical trial

[11] Lutz J(2020)SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor Proc Natl Acad Sci U S A 117 11727-2104

[12] Kowalczyk A(2020)Cell entry mechanisms of SARS-CoV-2 Nature 586 572-258

[13] Schlake T(2017)A vaccine targeting the RBD of the S protein of SARS-CoV-2 induces protective immunity Proc Natl Acad Sci U S A 114 E7348-3261

[14] Heidenreich R(2018)Immunogenicity and structures of a rationally designed prefusion MERS-CoV spike antigen Sci Rep 8 15701-1931

[15] Alberer M(2020)Stabilized coronavirus spikes are resistant to conformational changes induced by receptor recognition or proteolysis bioRxiv 92 2096-2438

[16] Gnad-Vogt U(2020)mRNA vaccine CVnCoV protects non-human primates from SARS-CoV-2 challenge infection J Med Virol 143 252-724

[17] Hong HS(1981)Evaluation of SARS-CoV-2 neutralizing antibodies using a CPE-based colorimetric live virus micro-neutralization assay in human serum samples J Infect Dis 108 3253-1374

[18] Mehr KT(2006)The effect of killed influenza virus vaccine on the kinetics of normal human lymphocytes Blood 383 1920-undefined

[19] Backert L(2020)Type I interferons directly regulate lymphocyte recirculation and cause transient blood lymphopenia N Engl J Med 383 2427-undefined

[20] Finak G(2020)An mRNA vaccine against SARS-CoV-2—preliminary report N Engl J Med 369 718-undefined

[11] Lutz J(2020)SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor Proc Natl Acad Sci U S A 117 11727-2104

[12] Kowalczyk A(2020)Cell entry mechanisms of SARS-CoV-2 Nature 586 572-258

[13] Schlake T(2017)A vaccine targeting the RBD of the S protein of SARS-CoV-2 induces protective immunity Proc Natl Acad Sci U S A 114 E7348-3261

[14] Heidenreich R(2018)Immunogenicity and structures of a rationally designed prefusion MERS-CoV spike antigen Sci Rep 8 15701-1931

[15] Alberer M(2020)Stabilized coronavirus spikes are resistant to conformational changes induced by receptor recognition or proteolysis bioRxiv 92 2096-2438

[16] Gnad-Vogt U(2020)mRNA vaccine CVnCoV protects non-human primates from SARS-CoV-2 challenge infection J Med Virol 143 252-724

[17] Hong HS(1981)Evaluation of SARS-CoV-2 neutralizing antibodies using a CPE-based colorimetric live virus micro-neutralization assay in human serum samples J Infect Dis 108 3253-1374

[18] Mehr KT(2006)The effect of killed influenza virus vaccine on the kinetics of normal human lymphocytes Blood 383 1920-undefined

[19] Backert L(2020)Type I interferons directly regulate lymphocyte recirculation and cause transient blood lymphopenia N Engl J Med 383 2427-undefined

[20] Finak G(2020)An mRNA vaccine against SARS-CoV-2—preliminary report N Engl J Med 369 718-undefined